参考文献

［1］American Society of Hospital Pharmacists. ASHP statement on the use of medications for unlabeled uses. American journal of health - system pharmacy，1992，49（8）：2006-2008.

［2］FAIRMAN K A，CURTISS F R. Regulatory actions on the off-label use of prescription drugs：ongoing controversy and contradiction in 2009 and 2010. Journal of managed care and specialty pharmacy，2010，16（8）：629-639.

［3］广东省药学会.关于印发《药品未注册用法专家共识》的通知.今日药学，2010，20（04）：1-3.

［4］广东省药学会.医疗机构超药品说明书用药管理专家共识.今日药学，2014，24（12），841-843.

［5］HAYNES R B. Of studies，syntheses，synopses，summaries，and systems：the “5S” evolution of information services for evidence-based healthcare decisions. Evid Based Nurs，2007，10（1）：6-7.

［6］SHEA B J，GRIMSHAW J M，WELLS G A，et al. Development of AMSTAR：a measurement tool to assess the methodological quality of systematic reviews. BMC medical research methodology，2007，7（1）：10.

［7］SHEA B J，REEVES B C，WELLS G，et al. AMSTAR 2：a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions，or both. The BMJ，2017，358：j4008.

［8］JADAD A R，MOORE R A，CARROLL D，et al. Assessing the quality of reports of randomized clinical trials：is blinding necessary？Contemporary clinical trials，1996，17（1）：1-12.